S100A12 and atrial fibrillation: Furthermore, we aimed to experimentally investigate the potential mechanism by which S100A12 contributes to new-onset AF in sepsis, examining the relationship between S100A12 expression, inflammation and AF, and assessing the efficacy of potential therapeutic agents for treating sepsis-induced new-onset AF.